G. Walmsley Graham - Dec 13, 2024 Form 4/A - Amendment Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
Director
Signature
/s/ Graham Walmsley
Stock symbol
OLMA
Transactions as of
Dec 13, 2024
Transactions value $
$0
Form type
4/A - Amendment
Date filed
12/18/2024, 06:52 PM
Date Of Original Report
Dec 17, 2024
Previous filing
Jun 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OLMA Common Stock Sale -$4.73M -701K -100% $6.75 0 Dec 13, 2024 See note F1, F3, F4
transaction OLMA Common Stock Purchase $4.73M +701K $6.75 701K Dec 13, 2024 See note F2, F3, F5
holding OLMA Common Stock 708K Dec 13, 2024 See note F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by Logos Opportunities Fund I LP ("Logos Fund I"). Logos Opportunities GP, LLC ("Logos Opportunities GP") is the general partner of Logos Fund I and the reporting person is a managing member of Logos Opportunities GP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
F2 The shares are held by Logos Opportunities Fund IV LP ("Logos Fund IV"). Logos Opportunities IV GP LLC ("GP IV") is the general partner of Logos Fund IV and the reporting person is a managing member of GP IV. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
F3 These securities were sold by Logos Fund I to Logos Fund IV. Logos Fund I and Logos Fund IV are under the common control of the Reporting Person.
F4 The Form 4 filed on December 17, 2024 identified the transaction date as December 17, 2024. The transaction date was December 13, 2024.
F5 The Form 4 filed on December 17, 2024, inadvertently reported the number of shares held by Logos Fund IV after the transaction as 1,408,875. As reported in this amended Form 4, the number of shares held by Logos Fund IV after the transaction is 700,761. The Form 4 also mistakenly reported the purchase of shares by Logos Fund IV as a disposition. The transaction was an acquisition. The transaction date was December 13, 2024.
F6 The shares are held by Logos Opportunities Fund II LP ("Logos Fund II"). Logos Opportunities GP is the general partner of Logos Fund II and the reporting person is a managing member of Logos Opportunities GP. The Form 4 filed on December 17, 2024, incorrectly reported these shares as being held by Logos Fund IV.